Clinical trial
Treatment of Parkinson's Disease With Eliprodil
NCT00001929 · National Institute of Neurological Disorders and Stroke (NINDS), NIH · Completed
Key facts
| NCT number | NCT00001929 |
|---|---|
| Title | Treatment of Parkinson's Disease With Eliprodil |
| Official title | NMDA-Receptor Blockade With Eliprodil in Parkinson's Disease |
| Lead sponsor | National Institute of Neurological Disorders and Stroke (NINDS), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Movement Disorders, Parkinson Disease |
| Intervention type | Drug |
| Interventions | Eliprodil |
| Enrollment | 20 |
| Start date | Mar 1, 1999 |
| Completion | Jan 1, 2001 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: